ABSTRACT
In this work, the effect of intake of fruit purees (guava-strawberry, guava-blackberry, guava-soursop, guava-passion fruit) by diabetic rats on reduction of plasma glucose and inflammation biomarkers was evaluated. Consumption of fruit purees in addition to a standard diet was associated with a reduction in body weight (20%), control of glucose metabolism, by decreasing plasma glucose (62.1%). We found a significant reduction in activities of alanine aminotransferase (49.41%), alkaline phosphatase (57.25%) and ϒ-glutamyl transferase (76%), which are useful markers of inflammatory process in the liver. Purees did not alter lipid metabolism and a remarkable improvement in liver morphology was observed. The diets order with the best beneficial effects was diet supplemented with guava-blackberry > guava-strawberry > guava-passion fruit > guava-soursop fruit. Consumption of fruit purees represent a therapeutic alternative by diabetic individuals.
Graphical Abstract
![](/cms/asset/e5b51a8d-dcf1-47c0-aa5a-fd3f50c97096/tcyt_a_1578267_uf0001_oc.jpg)
Resumen
En este trabajo, se evaluó el efecto de la ingesta de purés de frutas (guayaba, guayaba, mora, guanábana, guayaba y maracuyá) en ratas diabéticas sobre la reducción de la glucosa plasmática y biomarcadores de inflamación. El consumo de purés de fruta además de una dieta estándar se asoció con una reducción en el peso corporal (20%), control del metabolismo de la glucosa, al disminuir la glucosa en plasma (62,1%). Encontramos una reducción significativa en las actividades de alanina aminotransferasa (49.41%), fosfatasa alcalina (57.25%) y ϓ-glutamil transferasa (76%), que son marcadores útiles del proceso inflamatorio en el hígado. Los purés no alteraron el metabolismo de los lípidos y se observó una mejora notable en la morfología hepática. El orden de las dietas con los mejores efectos beneficiosos fue: dieta suplementada con puré de guayaba-zarzamora > guayaba-fresa, guayaba-maracuyá > guayaba-guanábana. El consumo de purés de frutas representa una alternativa terapéutica para los individuos diabéticos.
Disclosure statement
No potential conflict of interest was reported by the authors.
Acknowledgments
The authors acknowledge CONACYT-Mexico for the student scholarship (U.M. Morales-Ávila). Also, the authors acknowledge at Mr. John Philip Tolman and M.C. Emma Gabriela García López (Purés y Derivados de Nayarit) by the donation of all raw materials and participated directly in the project.
Supplementary material
Supplemental data for this article can be accessed on the publisher’s website.